| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $12.0M | +77.0% |
| Cost of Revenue | $3.5M | +0.0% |
| R&D Expense | $28.4M | -12.6% |
| SG&A Expense | $13.2M | -6.4% |
| Operating Income | -$29.7M | +31.6% |
| Interest Expense | $500K | +25.0% |
| Pre-tax Income | -$24.5M | +41.2% |
| Income Tax | $630K | +145.1% |
| Net Income | -$25.1M | +40.0% |
| EPS (Basic) | -$0.94 | +40.1% |
| EPS (Diluted) | -$0.94 | +40.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $35.0M | -20.8% |
| Short-term Investments | $41.6M | -19.0% |
| Current Assets | $79.3M | -19.8% |
| Total Assets | $80.8M | -20.5% |
| Current Liabilities | $18.0M | +20.9% |
| Long-term Debt | $4.9M | -7.5% |
| Total Liabilities | $53.1M | +5.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$19.5M | +51.5% |
| Capital Expenditures | $23K | -96.9% |
| Investing Cash Flow | $12.5M | +170.7% |
| Financing Cash Flow | -$569K | — |
| Free Cash Flow | -$19.6M | +52.3% |
| Stockholders' Equity |
| $27.7M |
| -46.0% |